ArticleEBioMedicine2020
Corrigendum to 'clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome'.
Abstract readPublished Erratum
In one paragraph
Article in EBioMedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Erratum for
Authors and funding
54 authors.
Suzy SchollInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France. Electronic address: suzy.scholl@curie.fr.
Marina PopovicGynecologic Oncology Department Clinic for Operative Oncology, Institute of Oncology of Vojvodina, Serbia.
Anne de la RochefordiereInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France.
Elodie GirardInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France.
Sylvain DureauInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France.
Aljosa MandicFaculty of Medicine Novi Sad, University of Novi Sad, Serbia.
Katarina KoprivsekGynecologic Oncology Department Clinic for Operative Oncology, Institute of Oncology of Vojvodina, Serbia; Faculty of Medicine Novi Sad, University of Novi Sad, Serbia.
Nina SametPublica Institutul Oncologic, Republic of Moldova.
Marius CrainaUniversity of Medicine and Pharmacy "Victor Babeș", Romania.
Madalin MarganUniversity of Medicine and Pharmacy "Victor Babeș", Romania.
Sanne SamuelsCenter for Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Henry ZijlmansCenter for Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Gemma KenterCenter for Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Peter HillemannsHannover Medical School, Germany.
Sorin DemaUniversity of Medicine and Pharmacy "Victor Babeș", Romania.
Alis DemaUniversity of Medicine and Pharmacy "Victor Babeș", Romania.
Goran MalenkovicFaculty of Medicine Novi Sad, University of Novi Sad, Serbia.
Branislav DjuranGynecologic Oncology Department Clinic for Operative Oncology, Institute of Oncology of Vojvodina, Serbia.
Anne FloquetChirurgie onco-gynécologique and Oncology, Institut Bergonié, Centre Régional de Lutte contre le Cancer Bordeaux-Aquitaine, France.
Delphine GarbayChirurgie onco-gynécologique and Oncology, Institut Bergonié, Centre Régional de Lutte contre le Cancer Bordeaux-Aquitaine, France.
Frédéric GuyonChirurgie onco-gynécologique and Oncology, Institut Bergonié, Centre Régional de Lutte contre le Cancer Bordeaux-Aquitaine, France.
Pierre Emmanuel ColomboCentre Val d'Aurelle, France.
Michel FabbroCentre Val d'Aurelle, France.
Christine KerrCentre Val d'Aurelle, France.
Charlotte NgoService de chirurgie cancérologique gynécologique et du sein, Hôpital Européen Georges Pompidou, APHP et faculté de médecine, Université Paris Descartes, France.
Fabrice LecuruService de chirurgie cancérologique gynécologique et du sein, Hôpital Européen Georges Pompidou, APHP et faculté de médecine, Université Paris Descartes, France.
Eleonor Rivin Del CampoDepartment of Radiation Oncology, Tenon University Hospital, Hôpitaux Universitaires Est Parisien, Sorbonne University Medical Faculty, Paris, France.
Charles CoutantCentre Georges François Leclerc, France.
Frédéric MarchalDépartement de chirurgie, CRAN, UMR 7039, Université de Lorraine, CNRS, Institut de Cancérologie de Lorraine, 6 avenue de Bourgogne - CS 30519 54519, Vandoeuvre-les-Nancy Cedex, France.
Nathalie Mesgouez-NeboutInstitut de cancérologie de l'Ouest - site Paul Papin (ICO) 15, Rue André Boquel, 49055 Angers, France.
Virginie FourchotteInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France.
Jean Guillaume FeronInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France.
Philippe MoriceGustave Roussy, France.
Eric DeutschGustave Roussy, France.
Pauline WimbergerDepartment of Gynecology and Obstetrics, Universitätsklinikum Carl Gustav Carus; an der Technischen Universität Dresden, Fetscherstraße 74, 01307 Dresden, Germany.
Jean-Marc ClasseRené Gauducheau, France.
Noreen GleesonSt James/Trinity College, Ireland.
Heiko von der LeyenHannover Clinical Trial Center GmbH, Germany.
Mathieu MinsatInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France.
Coraline DubotInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France.
Pierre GestraudInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France.
Attila KeresztSeqOmics Biotechnology Ltd, Vallalkozok utja 7, Morahalom, Hungary.
Istvan NagySeqOmics Biotechnology Ltd, Vallalkozok utja 7, Morahalom, Hungary.
Balazs BalintSeqOmics Biotechnology Ltd, Vallalkozok utja 7, Morahalom, Hungary.
Els BernsErasmus MC, The Netherlands.
Ekaterina JordanovaCenter for Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Nicolas de Saint-JorreQuanticsoft, France.
Alexia SavignoniInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France.
Nicolas ServantInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France.
Philippe HupeInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France.
Leanne de KoningInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France.
Pierre FumoleauInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France.
Roman RouzierInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France.
Maud KamalInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.